Sector: Health Care
Director information for REVOLUTION MEDICINES INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Alan Sandler, M.D. | Chief Development Officer | 69 | [] | [] | 2026 |
| Alexis Borisy | Director | 54 | [] | [] | 2026 |
| Elizabeth McKee Anderson | Director | 68 | [] | [] | 2026 |
| Flavia Borellini, Ph.D. | Director | 66 | [] | [] | 2026 |
| Frank K. Clyburn, Jr. | Director | 61 | [] | [] | 2026 |
| Lorence Kim, M.D. | Director | 52 | [] | [] | 2026 |
| Mark A. Goldsmith, M.D., Ph.D. | President, Chief Executive Officer and Chair of the Board; Chief Executive Officer, President and Chair of the Board; Chief Executive Officer (our “CEO”) and President | 64 | [] | [] | 2026 |
| Sandra J. Horning, M.D. | Director | 77 | [] | [] | 2026 |
| Sushil Patel, Ph.D. | Director | 55 | [] | [] | 2026 |
| Thilo Schroeder, Ph.D. | Director | 45 | [] | [] | 2026 |
